Clinical Trial Update: Endotoxin and Bronchial Inflammation in Asthma

View source ↗

Summary

Clinical trial from the University of North Carolina, Chapel Hill examining endotoxin exposure and bronchial inflammation in asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Asthma, Lung Diseases | Status: COMPLETED